The Changing Kinetics of Advanced Melanoma

Affiliations

Comment

Daniel G Coit. JAMA Dermatol. 2019.

. 2019 Jun 1;155(6):657-659.

doi: 10.1001/jamadermatol.2019.0200.

No abstract available

Comment on

Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival.
Vallet A, Oriano B, Mortier L, Dalle S, Dutriaux C, Guillot B, Leccia MT, Dalac S, Saiag P, Lacour JP, Legoupil D, De Quatrebarbes J, Brunet-Possenti F, Lesimple T, Arnault JP, Aubin F, Granel-Brocard F, Stoebner PE, Maubec E, Dreno B, Allayous C, Porcher R, Lebbé C; for MelBase. Vallet A, et al. JAMA Dermatol. 2019 Jun 1;155(6):673-678. doi: 10.1001/jamadermatol.2019.0425. JAMA Dermatol. 2019. PMID: 31042256 Free PMC article.
Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.
von Schuckmann LA, Hughes MCB, Ghiasvand R, Malt M, van der Pols JC, Beesley VL, Khosrotehrani K, Smithers BM, Green AC. von Schuckmann LA, et al. JAMA Dermatol. 2019 Jun 1;155(6):688-693. doi: 10.1001/jamadermatol.2019.0440. JAMA Dermatol. 2019. PMID: 31042258 Free PMC article.
Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.
Calomarde-Rees L, García-Calatayud R, Requena Caballero C, Manrique-Silva E, Traves V, García-Casado Z, Soriano V, Kumar R, Nagore E. Calomarde-Rees L, et al. JAMA Dermatol. 2019 Jun 1;155(6):679-687. doi: 10.1001/jamadermatol.2019.0069. JAMA Dermatol. 2019. PMID: 31042264 Free PMC article.